Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure
Fig 4
Kaplan-Meier survival estimates at 2 years according to clinical trial exclusion criteria among axial flow LVAD recipients enrolled in INTERMACS between 2010–2015.